AMGN

AMGEN INC

Health Care · Biotechnology

$67.60 sample

-0.22 (-0.32%) 1D

Market cap

$385.8B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-06

Alerts

8

Price$67.60 +5.33% 3M daily closessample

70.5862.94

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06SEC8-K filed: material event
Sep 25INSInsider sell: Chief Financial Officer
Sep 18INSInsider sell: General Counsel
Sep 14INSInsider buy: Chief Executive Officer
Sep 04INSInsider sell: General Counsel
Aug 26INSInsider sell: 10% owner
Aug 19INSInsider buy: General Counsel
Aug 11INSInsider sell: Chief Executive Officer

Sign up to see the real AMGN record →

Company facts

SEC EDGAR registration

Name: AMGEN INC
Sector: Health Care
Industry: Biotechnology
Smart-money score: -37sample, -100 to +100
Reporting currency: USD

Who is positioning in AMGN

sample

Insiders: 14 insider transactions over 90 days, net selling, $139.4M
Congress: 4 members traded over 90 days
Institutions · 13F: 34 funds hold $6.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.1B +17.0% y/y

Q4 2024Q3 2026

Inventory$12.4B +4.8% y/y

Q4 2024Q3 2026

Accounts receivable$9.8B +19.0% y/y

Q4 2024Q3 2026

Total debt$24.5B +9.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $216.9B -13.1% 3M
Sample peer B: $291.6B +6.7% 3M
Sample peer C: $122.8B +3.1% 3M
Sample peer D: $342.9B -6.1% 3M
Sample peer E: $79.3B -0.9% 3M